Sutro Biopharma Inc (STRO)
3.745
+0.36
(+10.47%)
USD |
NASDAQ |
May 01, 16:00
3.745
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Cash from Operations (TTM): -111.62M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -111.62M |
| September 30, 2023 | -149.55M |
| June 30, 2023 | -50.20M |
| March 31, 2023 | -22.19M |
| December 31, 2022 | 3.549M |
| September 30, 2022 | 5.833M |
| June 30, 2022 | -84.43M |
| March 31, 2022 | -86.50M |
| December 31, 2021 | -81.68M |
| September 30, 2021 | -78.98M |
| June 30, 2021 | -72.26M |
| Date | Value |
|---|---|
| March 31, 2021 | -79.50M |
| December 31, 2020 | -67.80M |
| September 30, 2020 | -62.08M |
| June 30, 2020 | -60.51M |
| March 31, 2020 | -63.61M |
| December 31, 2019 | -65.02M |
| September 30, 2019 | -57.80M |
| June 30, 2019 | 5.892M |
| March 31, 2019 | 7.548M |
| December 31, 2018 | 12.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-149.55M
Minimum
Sep 2023
5.892M
Maximum
Jun 2019
-62.02M
Average
-65.02M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
| Anika Therapeutics Inc | -1.788M |
| ABVC BioPharma Inc | -4.236M |
| Reviva Pharmaceuticals Holdings Inc | -28.32M |
| Flora Growth Corp | -8.396M |
| Journey Medical Corp | 5.24M |